Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CIMETIDINE
Rowex Ltd
400 Milligram
Coated Tablets
2001-02-27
IRISH MEDICINES BOARD ACT 1995 MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998 (S.I. NO.142 OF 1998) PA0711/044/002 Case No: 2035808 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to ROWEX LTD BANTRY, CO. CORK, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product CEDINE 400 MG FILM-COATED TABLETS The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 15/05/2007 until 26/02/2011. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 18/05/2007_ _CRN 2035808_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cedine 400 mg Film-Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains Cimetidine 400.00 mg. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-Coated Tablet Pale green, oblong, biconvex, film-coated tablets with a score notch on each side and engraved “C400” on one side. The score notch is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS CEDINE is indicated in the treatment of benign ulceration of the oesophagus, stomach upper intestinal tract (including post operative stomal area) and in the management o Read the complete document